Apollomics (Maxpro Capital Acquisition) ^{Priced, Nasdaq: APLM}

We are a newly-organized blank check company. While we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare and technology sectors, where our management team has extensive experience. Sectors we plan on exploring include, but are not limited to, technologically advanced segments of the medical, biotechnology, digital, data and data science, industrial, and financial fields. While we may pursue an initial business combination target in any industry or geographic location, we intend to focus our search on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business, focusing healthcare and technology industries, specifically within the biotechnology and pharmaceutical sectors. Our objective is to focus on middle market and emerging growth businesses operating with a total enterprise value from $200 million to $2 billion, which may be located throughout the world. There is no restriction in the geographic location of targets we can pursue, although we intend to initially prioritize North America, Europe and Asia as the geographical focus.